Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic t | DDDT
KIT D816 variant allele frequency (VAF), somatic mutations, and... | Download Scientific Diagram
Prognostic impact of c-Kit mutations in core binding factors -acute... | Download Scientific Diagram
Prognostic impact of KIT exon 17 mutations by allele-specific real-time... | Download Scientific Diagram
C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in mice | PNAS
Frontiers | Roles of Histone Deacetylases in Acute Myeloid Leukemia With Fusion Proteins
Oncogenic KIT mutations induce STAT3-dependent autophagy to support cell proliferation in acute myeloid leukemia | Oncogenesis
c-Kit Mutations in Human Tumors | Download Table
Frontiers | Targeted Therapies for Pediatric AML: Gaps and Perspective
TRUPCR® C-KIT Mutation Detection Kit | TRUPCR Europe
Pharmaceuticals | Free Full-Text | A Peptide Vaccine Design Targeting KIT Mutations in Acute Myeloid Leukemia
Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy - ScienceDirect
Unraveling novel genes that are essential for acute myeloid leukemia and normal hematopoiesis | Semantic Scholar
Comparison of relapse-free survival and overall survival in CBF-AML... | Download Scientific Diagram
KIT mutations in childhood CBF-AML. | Download Table
High Expression of c-kit mRNA Predicts Unfavorable Outcome in Adult Patients with t(8;21) Acute Myeloid Leukemia | PLOS ONE
Two cell lines of t(8;21) acute myeloid leukemia with activating KIT exon 17 mutation: models for the 'second hit' hypothesis | Leukemia
Profiling of somatic mutations and fusion genes in acute myeloid leukemia patients with FLT3-ITD or FLT3-TKD mutation at diagnosis reveals distinct evolutionary patterns | Experimental Hematology & Oncology | Full Text
Heterogeneous prognosis among KIT mutation types in adult acute myeloid leukemia patients with t(8;21) | Blood Cancer Journal
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia | NEJM
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis | Leukemia
A novel melting curve‑based method for detecting c‑kit mutations in acute myeloid leukemia
KIT and TET2 mutations in CBF-AML. (a) Mutations in KIT were... | Download Scientific Diagram
![PDF] Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/608cfe9e4c6abfd22f6b2e759828e3a21b729a43/4-Figure1-1.png "PDF] Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia | Semantic Scholar")
PDF] Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia | Semantic Scholar
Core-binding factor acute myeloid leukemia in pediatric patients enrolled in the AIEOP AML 2002/01 trial: screening and prognostic impact of c-KIT mutations | Leukemia
